Comments
Loading...

MiNK Therapeutics

INKTNASDAQ
$0.860300
-0.02-2.24%
Pre-Market: Jul 19, 7:40 PM EDT
15 minutes delayed

MiNK Therapeutics (NASDAQ:INKT) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
No data available to display

FAQ

Q

What is the most recent guidance for MiNK Therapeutics (INKT)?

A

There have been no specific sales or earnings guidance reported for MiNK Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch